Okairos is a Basel-Stadt-based company founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese and Stefano Colloca.
Fully integrated into GlaxoSmithKline since 2013, Okairos from BaselBasel developed T-cell based vaccines for major infectious diseases such as malaria, hepatitis C, HIV, and Ebola.
Fully integrated into GlaxoSmithKline since 2013, Okairos from Basel developed T-cell based vaccines for major infectious diseases such as malaria, hepatitis C, HIVHIV, and Ebola.
Fully integrated into GlaxoSmithKlineGlaxoSmithKline since 2013, Okairos from Basel developed T-cell based vaccines for major infectious diseases such as malaria, hepatitis C, HIV, and Ebola.
Fully integrated into GlaxoSmithKline since 2013, Okairos from Basel developed T-cell based vaccines for major infectious diseases such as malaria, hepatitis C, HIV, and Ebola.